Last Name

Search Results (30)

Click the Why column to see why an item matched the search.

Gamis, AlanPerson Why?
Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.Academic Article Why?
Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study.Academic Article Why?
Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.Academic Article Why?
CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients.Academic Article Why?
CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.Academic Article Why?
Earlier initiation of antibiotic therapy: Does prophylaxis offer greater benefit in AML?Academic Article Why?
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.Academic Article Why?
AmlodipineConcept Why?
Amlodipine Besylate, Olmesartan Medoxomil Drug CombinationConcept Why?
Amlodipine, Valsartan Drug CombinationConcept Why?
Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.Academic Article Why?
Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology Group.Academic Article Why?
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.Academic Article Why?
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.Academic Article Why?
Per Page    Page  of 2last Nextnext
Search Criteria
  • AML
Filter by Type